Compugen Ltd. (CGEN) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Compugen Ltd..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.149 -- 00:00:03.092 Ladies and gentlemen, thank you for joining us today. 00:00:03.092 -- 00:00:07.917 Welcome to CompuGen's first quarter 2025 results conference call. 00:00:07.917 -- 00:00:11.321 At this time, all participants are in listen-only mode. 00:00:11.321 -- 00:00:16.266 An audio webcast of this call is available in the Investors section of CompuGen's website, 00:00:16.266 -- 00:00:18.266 www.cgen.com. 00:00:18.348 -- 00:00:21.812 As a reminder, today's call is being recorded. 00:00:21.812 -- 00:00:27.158 I would now like to introduce Yvonne Naughton, Vice President, Head of Investor Relations 00:00:27.158 -- 00:00:31.351 and Corporate Communications, Yvonne, please go ahead. 00:00:31.351 -- 00:00:34.898 Thank you, operator, and thank you all for joining us on the call today. 00:00:34.898 -- 00:00:37.643 Joining me from Compogen for the prepared remarks are Dr. 00:00:37.643 -- 00:00:42.592 Anak Cohen-Diag, President and Chief Executive Officer, and David Zimmerman, Chief Financial 00:00:42.592 -- 00:00:46.340 Officer. Dr. Michelle Moller, Chief Medical Officer, and Dr. 00:00:46.340 -- 00:00:51.263 Ivana Burr, Chief Scientific Officer, will join us for the Q&A. 00:00:51.263 -- 00:00:54.547 Before we begin, we would like to remind you that during this call, the company may make 00:00:54.547 -- 00:00:58.492 projections of forward-looking statements regarding future events, business outlook, 00:00:58.492 -- 00:01:02.838 development efforts and their potential outcome, the company's discovery platform, anticipated 00:01:02.838 -- 00:01:07.343 progress and plans, results and timelines for our programs, financial and accounting-related 00:01:07.343 -- 00:01:12.410 matters, as well as statements regarding our cash position and cash runway. 00:01:12...